Search Results - "Olabisi, Oyenike O."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Non-canonical Smads phosphorylation induced by the glutamate release inhibitor, riluzole, through GSK3 activation in melanoma by Abushahba, Walid, Olabisi, Oyenike O, Jeong, Byeong-Seon, Boregowda, Rajeev K, Wen, Yu, Liu, Fang, Goydos, James S, Lasfar, Ahmed, Cohen-Solal, Karine A

    Published in PloS one (12-10-2012)
    “…Riluzole, an inhibitor of glutamate release, has shown the ability to inhibit melanoma cell xenograft growth. A phase 0 clinical trial of riluzole as a single…”
    Get full text
    Journal Article
  2. 2

    Ccpg1, a Novel Scaffold Protein That Regulates the Activity of the Rho Guanine Nucleotide Exchange Factor Dbs by Kostenko, Elena V., Olabisi, Oyenike O., Sahay, Sutapa, Rodriguez, Pedro L., Whitehead, Ian P.

    Published in Molecular and Cellular Biology (01-12-2006)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  3. 3

    Transformation by the Rho-specific Guanine Nucleotide Exchange Factor Dbs Requires ROCK I-mediated Phosphorylation of Myosin Light Chain by Liu, Zhuoming, Kostenko, Elena V., Mahon, Gwendolyn M., Olabisi, Oyenike O., Whitehead, Ian P.

    Published in The Journal of biological chemistry (09-06-2006)
    “…Dbs was identified in a cDNA-based expression screen for sequences that can cause malignant growth when expressed in murine fibroblasts. In previous studies we…”
    Get full text
    Journal Article
  4. 4

    RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion by Boregowda, Rajeev K, Olabisi, Oyenike O, Abushahba, Walid, Jeong, Byeong-Seon, Haenssen, Keneshia K, Chen, Wenjin, Chekmareva, Marina, Lasfar, Ahmed, Foran, David J, Goydos, James S, Cohen-Solal, Karine A

    Published in Cancer letters (28-06-2014)
    “…Abstract In the present study, we investigated the role of the transcription factor RUNX2 in melanomagenesis. We demonstrated that the expression of…”
    Get full text
    Journal Article
  5. 5

    Bcr interacts with components of the endosomal sorting complex required for transport-I and is required for epidermal growth factor receptor turnover by OLABISI, Oyenike O, MAHON, Gwendolyn M, KOSTENKO, Elena V, ZHUOMING LIU, OZER, Harvey L, WHITEHEAD, Ian P

    Published in Cancer research (Chicago, Ill.) (15-06-2006)
    “…Virtually all patients with chronic myelogenous leukemia (CML) express an aberrant protein (p210 Bcr-Abl) that contains NH2-terminal sequences from Bcr fused…”
    Get full text
    Journal Article
  6. 6

    Abstract 2906: Investigating the role of high c-Myc levels in the resistance to TGFβ-mediated tumor suppression in melanoma by Olabisi, Oyenike O., Cohensolal, Karine

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…Resistance to transforming Growth factor (TGF) β-mediated tumor suppression represents a major step in melanoma aggressiveness. At the cell surface, TGF-β…”
    Get full text
    Journal Article
  7. 7

    ROCK I-mediated activation of NF-κB by RhoB by Rodriguez, Pedro L., Sahay, Sutapa, Olabisi, Oyenike O., Whitehead, Ian P.

    Published in Cellular signalling (01-11-2007)
    “…RhoB is a short-lived protein whose expression is increased by a variety of extra-cellular stimuli including UV irradiation, epidermal growth factor (EGF) and…”
    Get full text
    Journal Article
  8. 8

    ROCK I-mediated activation of NF-kappaB by RhoB by Rodriguez, Pedro L, Sahay, Sutapa, Olabisi, Oyenike O, Whitehead, Ian P

    Published in Cellular signalling (01-11-2007)
    “…RhoB is a short-lived protein whose expression is increased by a variety of extra-cellular stimuli including UV irradiation, epidermal growth factor (EGF) and…”
    Get full text
    Journal Article